Cleo Diagnostics (ASX:COV) - Key People
ASX:COV · Directors, executives and key personnel · 12 month lookback
Mentioned in
Cleo Starts Formal Testing of Ovarian Cancer Assay Ahead of FDA Filing
13 Oct 2026
Healthcare Wrap - Week 37 (7 Sept -> 11 Sept) 2026
12 Sept 2026
Cleo Names Asuragen for 1,470-Sample Ovarian Cancer Test Validation
10 Sept 2026
Healthcare Wrap - Week 36 (31 Aug -> 4 Sept) 2026
5 Sept 2026
Also Mentioned
People named in Cleo Diagnostics (ASX:COV) articles over the last 12 months, by frequency.
Adrien Wing
· 30 articles
Andrew Stephens
· 28 articles
Lucinda Nolan
· 28 articles
Professor Tom Jobling
· 27 articles
Dayna Lou
· 15 articles
Nicholas Lambrou
· 4 articles
Tom Jobling
· 2 articles
J S Croall
· 2 articles
Tanushree Jain
· 2 articles
Jacob Hoenig
· 2 articles
Emma Lester
· 2 articles
Adrien Wing - Chair and Non-Executive Director
· 1 article
Richard Allman - Chief Executive Officer and Executive Director
· 1 article
Andrew Stephens - Chief Scientific Officer and Executive Director
· 1 article
Professor Tom Jobling - Non-Executive Director and Lead Medical Advisor
· 1 article
Lucinda Nolan - Non-Executive Director
· 1 article
Dayna Lou - Head of Corporate Development
· 1 article